{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:56Z","timestamp":1759017956525,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.annder.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T01:16:27Z","timestamp":1540602987000},"page":"723-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pigmentation du palais dur sous imatinib"],"prefix":"10.1016","volume":"145","author":[{"given":"N.","family":"Kluger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.09.003_bib0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1529-8019.2011.01431.x","article-title":"Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib","volume":"24","author":"Amitay-Laish","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2018.09.003_bib0035","first-page":"E12","article-title":"Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study","volume":"97","author":"Paolino","year":"2016","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2018.09.003_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.annder.2014.03.009","article-title":"Toxicit\u00e9 endobuccale des th\u00e9rapies cibl\u00e9es anti-canc\u00e9reuses","volume":"141","author":"Sibaud","year":"2014","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.09.003_bib0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.annder.2013.01.442","article-title":"Anomalies pigmentaires induites par les traitements anticanc\u00e9reux. Deuxi\u00e8me partie\u00a0: les th\u00e9rapies cibl\u00e9es","volume":"140","author":"Sibaud","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.09.003_bib0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/ijd.13931","article-title":"Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature","volume":"57","author":"Di Tullio","year":"2018","journal-title":"Int J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:47Z","timestamp":1758971207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0151963818305507"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.09.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pigmentation du palais dur sous imatinib","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}